Skip to content

Advertisement

Open Access

Erratum to: A randomised dose-ranging study of tiotropium Respimat® in children with symptomatic asthma despite inhaled corticosteroids

  • Christian Vogelberg1Email author,
  • Petra Moroni-Zentgraf2,
  • Migle Leonaviciute-Klimantaviciene3,
  • Ralf Sigmund4,
  • Eckard Hamelmann5,
  • Michael Engel2 and
  • Stanley Szefler6
Respiratory Research201516:128

https://doi.org/10.1186/s12931-015-0290-7

Received: 12 October 2015

Accepted: 12 October 2015

Published: 20 October 2015

The original article was published in Respiratory Research 2015 16:20

Erratum

Following publication of our article [1] we identified an error in Fig. 5, where results were inadvertently switched between morning and evening PEF responses. The corrected Fig. 5 is provided in this erratum. The PEF results provided in our original article text remain correct.
Fig. 5

Morning and evening PEF response after 4 weeks of treatment (full analysis set). Adjusted for ‘treatment’, ‘period’, ‘patient’ and ‘baseline’. *p < 0.05 versus placebo Respimat®. PEF, peak expiratory flow

Notes

Declarations

Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.

Authors’ Affiliations

(1)
University Hospital Carl Gustav Carus, Technical University of Dresden, Dresden, Germany
(2)
Boehringer Ingelheim Pharma GmbH & Co. KG, Ingelheim am Rhein, Germany
(3)
Vilnius University Hospital, Vilnius, Lithuania
(4)
Boehringer Ingelheim Pharma GmbH & Co. KG, Biberach an der Riss, Germany
(5)
Evangelisches Krankenhaus Bielefeld, Bielefeld, Germany
(6)
Department of Pediatrics, Children’s Hospital of Colorado and the University of Colorado Denver School of Medicine, Aurora, USA

Reference

  1. Vogelberg C, Moroni-Zentgraf P, Leonaviciute-Klimantaviciene M, Sigmund R, Hamelmann E, Engel M, et al. A randomised dose-ranging study of tiotropium Respimat® in children with symptomatic asthma despite inhaled corticosteroids. Respir Res. 2015;16:20.View ArticlePubMedPubMed CentralGoogle Scholar

Copyright

© Vogelberg et al. 2015

Advertisement